KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $7.4.

  • Eli Lilly's EPS (Basic) rose 5102.04% to $7.4 in Q4 2025 from the same period last year, while for Dec 2025 it was $22.99, marking a year-over-year increase of 9549.32%. This contributed to the annual value of $23.0 for FY2025, which is 9557.82% up from last year.
  • Eli Lilly's EPS (Basic) amounted to $7.4 in Q4 2025, which was up 5102.04% from $6.22 recorded in Q3 2025.
  • Eli Lilly's 5-year EPS (Basic) high stood at $7.4 for Q4 2025, and its period low was -$0.06 during Q3 2023.
  • In the last 5 years, Eli Lilly's EPS (Basic) had a median value of $2.04 in 2022 and averaged $2.68.
  • Per our database at Business Quant, Eli Lilly's EPS (Basic) plummeted by 10372.67% in 2023 and then skyrocketed by 190000.0% in 2024.
  • Eli Lilly's EPS (Basic) (Quarter) stood at $1.9 in 2021, then increased by 13.16% to $2.15 in 2022, then rose by 13.02% to $2.43 in 2023, then surged by 101.65% to $4.9 in 2024, then soared by 51.02% to $7.4 in 2025.
  • Its last three reported values are $7.4 in Q4 2025, $6.22 for Q3 2025, and $6.3 during Q2 2025.